KPTI - Karyopharm Therapeutics Inc.

QQQ $ 441.71 $ 1.04 (0.24 %)

DIA $ 395.04 $ 1.18 (0.3 %)

SPY $ 520.76 $ 0.67 (0.13 %)

TLT $ 90.14 $ -0.51 (-0.56 %)

GLD $ 218.73 $ 1.76 (0.81 %)

Previous Close

$ 1.09

Open

$ 1.06

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 1.02 - $ 1.10

52 Week Range

$ 0.62 - $ 2.76

Volume

1,129,908

Average Volume

Market Cap

125.84M

Beta (5Y Monthly)

$ 1.11

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-08-2024	03-31-2024	10-Q
2	02-29-2024	12-31-2023	10-K
3	11-02-2023	09-30-2023	10-Q
4	08-02-2023	06-30-2023	10-Q
5	05-04-2023	03-31-2023	10-Q
6	02-17-2023	12-31-2022	10-K
7	11-03-2022	09-30-2022	10-Q
8	08-04-2022	06-30-2022	10-Q
9	05-05-2022	03-31-2022	10-Q
10	03-01-2022	12-31-2021	10-K
11	11-03-2021	09-30-2021	10-Q
12	08-05-2021	06-30-2021	10-Q
13	05-04-2021	03-31-2021	10-Q
14	02-24-2021	12-31-2020	10-K
15	11-02-2020	09-30-2020	10-Q
16	08-04-2020	06-30-2020	10-Q
17	05-05-2020	03-31-2020	10-Q
18	02-26-2020	12-31-2019	10-K
19	11-04-2019	09-30-2019	10-Q
20	08-07-2019	06-30-2019	10-Q
21	05-09-2019	03-31-2019	10-Q
22	02-28-2019	12-31-2018	10-K
23	11-08-2018	09-30-2018	10-Q
24	08-07-2018	06-30-2018	10-Q
25	05-10-2018	03-31-2018	10-Q
26	03-15-2018	12-31-2017	10-K
27	11-02-2017	09-30-2017	10-Q
28	08-08-2017	06-30-2017	10-Q
29	05-04-2017	03-31-2017	10-Q
30	03-16-2017	12-31-2016	10-K
31	11-07-2016	09-30-2016	10-Q
32	08-04-2016	06-30-2016	10-Q
33	05-09-2016	03-31-2016	10-Q
34	03-15-2016	12-31-2015	10-K
35	11-09-2015	09-30-2015	10-Q
36	08-10-2015	06-30-2015	10-Q
37	05-11-2015	03-31-2015	10-Q
38	03-13-2015	12-31-2014	10-K
39	11-10-2014	09-30-2014	10-Q
40	08-07-2014	06-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

HC Wainwright & Co. Reiterates Buy on Kary...
05/09/2024 10:53:41

HC Wainwright & Co. analyst Edward White reiterates Karyopharm Therapeutics (NASDAQ:KPTI) with a Buy and maintains $8 pr...

Karyopharm Announces Refinancing Transacti...
05/08/2024 11:39:20

Karyopharm Therapeutics Reaffirms 2024 Rev...
05/08/2024 11:39:20

Karyopharm Therapeutics Q1 2024 GAAP EPS $...
05/08/2024 11:38:06

Karyopharm Therapeutics (NASDAQ:KPTI) reported quarterly losses of $(0.32) per share which beat the analyst consensus estimate ...

Karyopharm Announces Presentations In Endo...
04/24/2024 20:42:32

Invited to Present Updated Endometrial Cancer Data During Special Session "ASCO Plenary Series: Rapid Abstract Updates"...

Onco360 Selected As The Preferred National...
03/13/2024 20:38:15

Onco360®, the nation's largest independent Oncology Pharmacy, is now the national specialty pharmacy network partner for Ka...

HC Wainwright & Co. Maintains Buy on Karyo...
03/01/2024 12:10:52

HC Wainwright & Co. analyst Edward White maintains Karyopharm Therapeutics (NASDAQ:KPTI) with a Buy and lowers the price...

Karyopharm Sees 2024 Total Revenue $140M-$...
02/29/2024 12:31:56

Karyopharm Therapeutics Q4 2023 GAAP EPS $...
02/29/2024 12:31:15

Karyopharm Therapeutics (NASDAQ:KPTI) reported quarterly losses of $(0.36) per share which missed the analyst consensus estimat...

Earnings Scheduled For February 29, 2024
02/29/2024 10:15:24

Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on reve...

Karyopharm Therapeutics's Earnings: A Preview
02/28/2024 19:01:25

12-health-care-stocks-moving-in-tuesdays-intraday-session

12 Health Care Stocks Moving In Tuesday's ...
02/06/2024 17:31:29

12-health-care-stocks-moving-in-mondays-intraday-session

12 Health Care Stocks Moving In Monday's I...
02/05/2024 17:31:04

Watching Karyopharm Therapeutics; Traders ...
02/05/2024 17:23:25

12-health-care-stocks-moving-in-mondays-pre-market-session

12 Health Care Stocks Moving In Monday's P...
02/05/2024 13:06:14

12-health-care-stocks-moving-in-wednesdays-after-market-session

12 Health Care Stocks Moving In Wednesday'...
01/31/2024 21:31:06

Karyopharm Expects Preliminary Unaudited F...
01/08/2024 13:59:15

Karyopharm Shares Data At ASH 2023 Showing...
12/11/2023 06:40:27

Biomarker Data from Phase 1 Study of Selinexor in Combination with Ruxolitinib in Treatment-Naïve Myelofibrosis (MF) Suggesti...

Karyopharm Therapeutics Announced The Pres...
11/06/2023 12:19:25

Piper Sandler Maintains Overweight on Kary...
11/03/2023 21:16:24

Piper Sandler analyst Christopher Raymond maintains Karyopharm Therapeutics (NASDAQ:KPTI) with a Overweight and lowers the p...